ProtoKinetix Inc (PKTX)

[PK holder]

The TBRA stock going from $5 to $40 is they announce on sept 12th they are entering phase 1 trials and 8 days later they get a take over offer from Allergan. Allergan is trailing Intercept in their battle for this NASH disease so the fascinating point to take from this is. The AAGP molecule which can be seen in two studies for Diabetes and Regenerative tissue can clearly help a Pharma company in many ares. Getting to phase 1 for PKTX the possibilities are endless. Big pharma pays big time for anything that they see helping them not only right away but down the road.